Cell Surgical Network (CSN) has partnered with American Cryostem (ACS) and has recently received approval from ICSS to study the safety of banking and expanding adipose derived stromal vascular fraction. Both companies see this as the future of regenerative medicine: bank young healthy cells and have them available when injury or illness occur. A practice already well-established within the cord blood stem cell community, it seems natural to offer similar services for SVF. For more information please visit: http://stemcellrevolution.com/
